Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 63.42M P/E - EPS this Y - Ern Qtrly Grth -
Income -39.77M Forward P/E -2.45 EPS next Y 35.10% 50D Avg Chg -19.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -26.00%
Dividend N/A Price/Book 12.67 EPS next 5Y - 52W High Chg -48.00%
Recommedations 2.00 Quick Ratio 0.56 Shares Outstanding 98.29M 52W Low Chg 4.00%
Insider Own 1.93% ROA -68.26% Shares Float 86.29M Beta 1.16
Inst Own 8.00% ROE -262.37% Shares Shorted/Prior 836.78K/628.25K Price 0.74
Gross Margin - Profit Margin - Avg. Volume 273,682 Target Price 4.80
Oper. Margin - Earnings Date Nov 8 Volume 380,742 Change 0.68%
About Dare Bioscience, Inc.

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder; and DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy. The company's Phase I-ready products are DARE-VVA1, a proprietary formulation of tamoxifen for intravaginal to treat vulvar vaginal atrophy in women with hormone-receptor positive breast cancer; DARE-PDM1, a proprietary hydrogel formulation of diclofenac, a nonsteroidal anti-inflammatory drug, for vaginal administration as a treatment for dysmenorrhea; DARE-204 and DARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-GML, an intravaginally-delivered potential multi-target antimicrobial agent formulated with glycerol monolaurate; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Dare Bioscience, Inc. News
09/21/23 Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
09/20/23 Daré Bioscience to Present at The Menopause Society 2023 Annual Meeting
09/06/23 Daré Bioscience to Participate in Upcoming Investor Conferences
09/05/23 Daré Bioscience Completes Previously Announced Equity Financing
08/30/23 Daré Bioscience Announces $7.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
08/12/23 Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2023 Earnings Call Transcript
08/10/23 Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
08/10/23 Daré Bioscience Reports Second Quarter 2023 Financial Results and Provides a Company Update
08/09/23 Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a Phase 1/2 Clinical Trial of DARE-HRT1 Intravaginal Rings
08/03/23 Daré Bioscience to Host Second Quarter 2023 Financial Results and Company Update Conference Call and Webcast on August 10, 2023
07/31/23 Daré Bioscience Announces Grant Award Supporting Development of Potential New Therapeutic Intervention for the Prevention of Idiopathic Preterm Birth
07/29/23 Investors in Daré Bioscience (NASDAQ:DARE) have unfortunately lost 33% over the last five years
07/11/23 Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems
07/11/23 Daré Bioscience Announces Additional Positive Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women
07/06/23 Daré Bioscience Announces Upcoming Webinar to Review Additional Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder
07/05/23 Daré Bioscience Provides Update on Activities to Support Commercial Launch of XACIATO™ (clindamycin phosphate) vaginal gel, 2%, FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis
06/21/23 Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women
06/18/23 We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully
06/14/23 Daré Bioscience to Present at the Maxim Group Virtual Healthcare Conference
06/09/23 Daré Bioscience Announces Publication of Phase 1/2 Pharmacokinetic, Safety and Pharmacodynamic Data for DARE-VVA1 - a Potential New Hormone-Free Treatment for Vulvovaginal Atrophy - in Climacteric, the Journal of the International Menopause Society
DARE Chatroom

User Image NoToConArtists Posted - 1 hour ago

$DARE FRAUD

User Image yaestoyaqui Posted - 1 hour ago

$DARE - Market cap, 50M,ridiculous 👀 🔥 - Good news is coming!!! easy short squeeze this week. It is advisable to buy a few and wait for the moment, which will soon come

User Image Thecannonbull Posted - 2 hours ago

$DARE Need some volatility here, dont care what direction just some volume, this shits watching paint dry

User Image NoToConArtists Posted - 4 hours ago

$DARE fraud

User Image yaestoyaqui Posted - 4 hours ago

$DARE - Market cap, 46M,ridiculous 👀 🔥 - Good news is coming! easy short squeeze this week. It is advisable to buy a few and wait for the moment, which will soon come Sept. 21, 2023 Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it will receive a payment of approximately $4.5 million as the latest installment under a grant agreement to advance the development of Daré’s investigational contraceptive

User Image NoToConArtists Posted - 4 hours ago

$DARE FRAUD

User Image yaestoyaqui Posted - 4 hours ago

$DARE add more , buy🚀 💎💎 Squeeze soon!!!!!

User Image Stress3 Posted - 5 hours ago

$DARE almost not worth arguing with a cheerleader who is never right, but Dare isn’t “dripping like a leaky faucet,” it plunged downward. And leaking isn’t the problem either, the very real threat of a reverse stock split is. This is now unlikely fixable by Xaciato sales. It may push it up a little, maybe close to $1, but it’s not sustainable simply because Dare won’t have any other products for years. Xaciato alone won’t save this company. And before you come at me, this slight bump up this morning won’t last either and it certainly won’t prevent a reverse stock split. Had Sabrina not given false time frames for the progress of Xaciato and Ovaprene third trial, the stock price would not have gotten so low. It is in the danger zone now. This is much more serious than your leaking faucet analogy

User Image Delthefunkeehomosapian Posted - 6 hours ago

$DARE Until sales of X we are gonna continue to drip like a leaky facet. Nothing else matters.

User Image behindcl0seddr Posted - 22 hours ago

$DARE everyone dies I’m the end here

User Image TonyKLestor Posted - 1 day ago

$DARE No takers. LOL, gee, what a shock!!

User Image Stress3 Posted - 2 days ago

$DARE it’s interesting that even at .45, cheerleaders think it’s gonna be ok. How? How am I, or others spreading misinformation by stating the obvious. It’s obvious to anyone with half a brain, but not to Del or Jedi, or a few that use long complicated poster names that say it’s gonna fly any second. How will this fly? Why would this fly? Delusional, or maybe Del, you are a paid pumper. I am not like you, not accusing, just wondering, are you paid to say all is good here? Are you losing money, or making money here by promoting a dud? Likely will reverse stock split. No one is happy about that, or they shouldn’t be.

User Image Garymoved Posted - 2 days ago

$DARE

User Image Garymoved Posted - 2 days ago

$DARE Strong Buy!

User Image stockmani Posted - 2 days ago

$DARE Buy or hold or sell ?

User Image Sabren Posted - 2 days ago

$DARE Couldn't trigger my buy order today. Try again next week.

User Image BiotechJedi1728 Posted - 3 days ago

$DARE You may hate what happened with OGN and Xaciato, but regardless, this is waaaaay oversold. Expect a big turnaround to .65 - .80 soon. If coincident with PR drops, the reversal here will be monumental.

User Image NoToConArtists Posted - 3 days ago

$DARE FRAUD

User Image yaestoyaqui Posted - 3 days ago

$DARE 🔥THESE SHORTS WILL BURN 🔥 add more , buy🚀 💎💎 Squeeze soon!!

User Image NoToConArtists Posted - 3 days ago

$DARE FRAUD

User Image yaestoyaqui Posted - 3 days ago

$DARE - Market cap, 46M,ridiculous 👀 🔥 - Good news is coming! easy short squeeze this week. It is advisable to buy a few and wait for the moment, which will soon come Sept. 21, 2023 Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it will receive a payment of approximately $4.5 million as the latest installment under a grant agreement to advance the development of Daré’s investigational contraceptive

User Image Stress3 Posted - 3 days ago

$DARE This company is failing. Stock price is a disaster. No product release, despite Sabrina announcing over and over false time frames. Ovaprene third study hasn’t started yet. They secured with strings funding for Larc1 that is no where near ready for release btw. How do cheerleaders sugar coat that? You know how, they blame those that point out this has been a terrible investment and that Sabrina is to blame for the failures of this company. They don’t blame Sabrina cause that makes too much sense. They blame those that say it out loud. And somehow they think people who say out loud they are losing money, are really making money. There’s no logic with that kind of thinking. Some of the cheerleaders still think it’s all fine though, except for those pesky truth tellers, the ones they blame for Sabrina’s failures. Cheerleaders even say a buyout will happen and will save the day. It won’t, even on the slim chance that happens. A reverse split is likely. They won’t admit that though.

User Image NoToConArtists Posted - 3 days ago

$DARE FRAUD

User Image yaestoyaqui Posted - 3 days ago

$DARE and at the beginning of the year it was above $1.20.... soon🚀🔥 squeeze! ready? Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it will receive a payment of approximately $4.5 million https://ir.darebioscience.com/news-releases/news-release-details/dare-bioscience-announces-grant-funding-installment-support

User Image albion Posted - 3 days ago

$DARE I have a number of other good bios ckpt hoth etc, which have important drugs for potentially treating cancer, but what's impressive about dare is that they get grants of millions from donors

User Image Punted Posted - 3 days ago

$DARE well @RayRaySamuelz_MMXXIII ?

User Image Punted Posted - 3 days ago

$DARE just surreal biotechjedi1728 (aka biotechfraud: the phd the scientist the patent holder the manager of 30 the one running a phase 1 is again insisting xaciato is being sold right now. how is this ok?

User Image RayRaySamuelz_MMXXIII Posted - 3 days ago

$DARE Going golfing in a couple hours. Putting the same orders out there again today, buys and sells. I expect more low volume range bound nonsense, but I guess we'll see. Have a great weekend everyone, we're all truly blessed whether we choose to acknowledge it or not.

User Image Stress3 Posted - 3 days ago

$DARE it’s probably that I’ve blocked numerous people that I don’t see that negativity much anymore. Now, I’m not reading much of what the cheerleaders and liars post. I read mostly what other frustrated investors post and I’m not the only one, but I’m the main subject of attack. Hey, here’s an idea. If my “volumous” posts bother you, block me and don’t read them. There’s others that say similar to what I say, and a few that write it way better than I do, and they don’t get a mention. Many of us think Sabrina is a lousy CEO. Many of us noticed her missed time frames and called it how it would affect the stock and it has. Many of us think there will be a reverse stock split. It’s not just me. We didn’t cause this failure of Dare. Many of us are losing big and think it was unnecessary. Sabrina isn’t doing her job. We see she doesn’t care about the investor. That’s not my fault. I hate being right. I’d much rather not be losing money. Since I am, I’ll post about it, just like others are.

User Image Stress3 Posted - 3 days ago

$DARE it’s funny because someone just brought to my attention a nasty post from someone who knows nothing. First, I am a worried investor. I’m losing tons here. Secondly, wanting to be able to make a profit is what absolutely every investor wants. I’m not asking anyone to take a loss by me hoping this loser company turns around and I can sell my shares. If I were making a profit now, no matter if the pipeline suddenly started coming out, I’m done with this company. It’s like an old car, and wanting a new one. I’m no different than any of you, tired of this company, wanting to make money. Instead of bashing me for it, tell Sabrina she’s a lousy CEO. I am not spreading fear and I’m not paid. I have unfortunately called it right every time, something the cheerleaders get upset about, as maybe some of them are paid pumpers. I’m not. How would me losing money be a benefit to me? Anyway, I still think there will be a reverse split. That’s the road Dare is on. That’s not my fault. Blame CEO

Analyst Ratings
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy Jul 13, 23
HC Wainwright & Co. Buy Jun 6, 23
HC Wainwright & Co. Buy May 22, 23
HC Wainwright & Co. Buy May 12, 23
HC Wainwright & Co. Buy Mar 31, 23
HC Wainwright & Co. Buy Dec 13, 22
JonesTrading Buy Dec 1, 22
HC Wainwright & Co. Buy Apr 1, 22